Attagene Inc.

Attagene Inc. is a corporate entity registered in SAM.gov since 2007, located in Morrisville, North Carolina, and recognized as a self-certified small disadvantaged business. The company specializes in advanced bioanalytical services, with a particular focus on transcription factor profiling and sophisticated molecular analysis techniques. Attagene's core expertise lies in developing innovative platforms for assessing biological impacts of chemicals, environmental samples, and potential drug candidates, leveraging its proprietary technological approach called the Factorial platform for quantitative transcription factor activity profiling.

The company has secured several federal contract awards, primarily from the Environmental Protection Agency (EPA) and U.S. Geological Survey, focusing on specialized scientific analysis services. These contracts have included drinking water sample analysis following Hurricane Maria, transcription factor profiling for chemical mixture assessments, and bioanalytical services to evaluate environmental and chemical impacts. Each contract was awarded as a firm fixed-price purchase order, ranging from approximately $69,000 to $250,000, and were non-competitively awarded due to Attagene's unique analytical capabilities. The contracts were not designated with specific small business set-asides, though Attagene is certified as a small disadvantaged business.

Attagene has received federal grant awards from agencies including the National Institute of Environmental Health Sciences (NIEHS) and the National Cancer Institute, supporting advanced research projects. These grants focus on developing innovative scientific methodologies, such as a two-tier water bioactivity surveillance system called WASANET and a novel approach for assigning modes of action to anticancer drug leads from natural products. The grants range from approximately $600,000 to $1 million and support cutting-edge research in environmental health, water quality assessment, and drug discovery. The project periods typically span two to three years, demonstrating the company's commitment to advancing scientific understanding through sophisticated molecular and cellular analysis techniques.